Longboard Pharmaceuticals Announces Speakers for Investor & Analyst Event in New York on October 11, 2023

Longboard Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the speakers for its...

Related Keywords

United States ,Ukraine ,New York ,Australia ,Philadelphia ,Pennsylvania ,Gabrielle Conecker ,Dennis Dlugos ,A Alliance ,Nasdaq ,Exchange Commission ,Longboard Pharmaceuticals Inc ,Epilepsy Study Consortium ,Longboard Pharmaceuticals ,Analyst Event ,Epileptic Encephalopathy ,Vice President ,Principal Investigator ,Executive Director ,Decoding Developmental Epilepsies ,Investor Relations ,Private Securities Litigation Reform Act ,Markets ,